Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Scholar Rock Holding Corporation (SRRK : NSDQ)

• Company Description    Scholar Rock Holding Corporation is a biopharmaceutical company. It focused on the discovery and development of medicines for treatment of serious diseases. The company's product candidate includes SRK-015 and BMP6 which is in pre-clinical stage. Scholar Rock Holding Corporation is based in Cambridge, United States. Number of Employees: 289

• Price / Volume Information    Yesterday's Closing Price: $48.13 Daily Weekly Monthly 20 Day Moving Average: 1,249,444 shares Shares Outstanding: 119.83 (millions) Market Capitalization: $5,767.32 (millions) Beta: 0.70 52 Week High: $51.63 52 Week Low: $27.07 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 1.37% -3.58% 12 Week 7.34% -0.77% Year To Date 9.26% -0.40%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 301 BINNEY STREET 3RD FLOOR - CAMBRIDGE,MA 02142 USA ph: 857-259-3860 fax: 866-493-4935 ir@scholarrock.com http://www.scholarrock.com

• General Corporate Information    Officers David Halla - Chief Executive Officer Vikas Sinha - Chief Financial Officer Srinivas Akkaraju - Director Joshua Reed - Director Katie Peng - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 80706P103 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/05/26 Share - Related Items Shares Outstanding: 119.83 Most Recent Split Date: (:1) Beta: 0.70 Market Capitalization: $5,767.32 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.86 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-3.18 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 10.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 36.31% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/05/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 20.90 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -23.88% vs. Previous Quarter: 5.68% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/26 - -163.52 12/31/25 - -145.91 09/30/25 - -121.95 ROA 03/31/26 - -96.67 12/31/25 - -96.68 09/30/25 - -86.51 Current Ratio 03/31/26 - 8.64 12/31/25 - 6.95 09/30/25 - 6.30 Quick Ratio 03/31/26 - 8.64 12/31/25 - 6.95 09/30/25 - 6.30 Operating Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Net Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Pre-Tax Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Book Value 03/31/26 - 2.30 12/31/25 - 2.41 09/30/25 - 2.55 Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Equity 03/31/26 - 0.71 12/31/25 - 0.41 09/30/25 - 0.41 Debt-to-Capital 03/31/26 - 41.60 12/31/25 - 28.89 09/30/25 - 28.91

Powered by Zacks Investment Research ©